                </a></li></ul></div><p><strong>Figure 6.  <span>Lymph node-resident and tissue-derived trafficking DC prime naïve influenza HA-specific CD8<sup>+</sup> and CD4<sup>+</sup> T cells following s.c. infection with influenza PR8.</span></strong></p><a id="article1.body1.sec2.sec2.fig3.caption1.p1" name="article1.body1.sec2.sec2.fig3.caption1.p1"></a><p>Naïve BALB/c mice infected with influenza virus (PR8) by s.c. injection. 48 (<em>A,B</em>) or 72 h (<em>C,D</em>) after infection, DC were enriched from the popliteal lymph nodes and flow cytometrically purified into Langerhans cells (CD11c<sup>+</sup> CD205<sup>+</sup>), dermal DC (CD11c<sup>+</sup> CD205<sup>int</sup>), CD8α (CD11c<sup>+</sup> CD8<sup>+</sup>) DC or DN (CD11c<sup>+</sup>CD8<sup>−</sup>CD205<sup>−</sup>) before culturing titrating numbers of purified DC with 5×10<sup>4</sup> CFSE-labelled CD8<sup>+</sup> (CL4) or CD4<sup>+</sup> (HNT) T cells specific for the HA epitopes of influenza. The x-axis shows the range of DC used as stimulators over different experiments (<em>A,B</em>) or the number of DC (<em>C,D</em>) used in each well. Proliferation was analysed at 60 hr of culture. Data represent the mean±SEM of four (<em>A,B</em>) and three (<em>C,D</em>) independent experiments.</p>
